Chris Rozell traveled to Washington, D.C. to share the impacts of the past decade of brain research funded by the NIH BRAIN Initiative with Congress — and share with local representatives how Georgia Tech is playing a key role in leading the charge.
Across Georgia Tech, researchers, scientists, and students are creating the next breakthroughs in understanding this complex system, treatments of neurological diseases and injuries, and tools to improve neural function.
Across Georgia Tech, researchers, scientists, and students are creating the next breakthroughs in understanding this complex system, treatments of neurological diseases and injuries, and tools to improve neural function.
EnerCage wirelessly powers electronic devices and sensors traditionally used during rodent research experiments, without interconnect wires or batteries.
A new microfluidic device for capturing rare circulating tumor cells (CTCs) is the first designed specifically to capture clusters of two or more cells.
New acoustic device research reveals even a healthy knee makes cringeworthy sounds. But the audio can be turned into graphs, and researchers hope they will some day become medically useful.
Researchers at the Georgia Institute of Technology have found a detection method that could revolutionize cancer treatment by showing how cancers metastasize and what stage they are.
The French National Research Agency has awarded a grant to Georgia Tech and Georgia Tech-Lorraine researchers to develop technology for a new class of cochlear implants.
Clinical work begins with MagTrack, a cutting-edge assistive technology that enables power wheelchair users to control their connected devices and drive their power wheelchairs using an alternative, multimodal controller.
Surveillance testing for Covid-19 is critical, even for those who are vaccinated, because it is the only way to detect an infection before it puts others at risk.
A study from researchers at Georgia Tech and Georgia State University finds that Covid-19 patients experience a higher level of disability caused by lower gray matter volume in the front region of the brain.
